Our findings identify the PGM5-AS1/miR-423-5p/SLIT2 axis as a potential underlying mechanism of NSCLC progression and thus provide a potential target for the prevention or treatment of NSCLC. This evidence concerns the gene PGM5 and non-small cell lung carcinoma.